Creating the center of excellence for SMI care through a precision medicine approach, real-world clinical research, and best-in class provider education.
Pairing high quality care, with a precision medicine approach, best-in-class provider education, and real-world clinical research to deliver exceptional patient outcomes while advancing the field of psychiatry.
Our priority and focus on Amae, delivered by an integrated team of psychiatrists, therapists, health coaches, primary care physicians, and peers.
Learn MoreLeveraging current and historical patient data and AI built on Palantir Foundry to deliver personalized, data-driven care.
Learn MoreInnovative training techniques co-developed between Amae and MGH, delivered to all Amae clinicians across all clinics.
Learn MoreConducting novel research and harnessing SMI patient insights through technology to advance the field of psychiatry.
Learn MoreCMO & Psychiatrist
We combine historical EHR data with real-time physical and mental health insights to deliver truly personalized care for our patients. Through our unique longitudinal treatment, we track real-world outcomes and continuously refine our approach—resulting in more precise interventions and better long-term outcomes.
Computer Adaptive Testing for Mental Health (CAT-MH)
Metabolic Testing
Genomics
Patient Medical Records
Longitudinal Treatment Data
Biometric Data
Amae uses the CAT-MH (Computerized Adaptive Test for Mental Health), a validated, adaptive tool that continuously measures and tracks mental health symptoms based on patient self-reporting. Results in our first year from our patient cohort at our LA clinic showed a reduction in SMI symptom severity & improved treatment precision.
Our precision medicine approach achieves consistently better outcomes than standard care — reducing readmissions, shortening hospital stays, and improving adherence and engagement for our patients.
In Collaboration with:
Amae is collaborating with Massachusetts General Hospital to co-develop and facilitate clinical training for all Amae Health clinicians—ensuring every provider is equipped with the knowledge, tools, and support to deliver exceptional, evidence-based care for our patients. Together, we’re building a gold-standard educational framework to drive consistency and quality across Amae.
Advancing real-world research to transform SMI care—embedding clinical studies into treatment to drive better outcomes and redefine what’s possible.
In Collaboration with:
Amae has partnered with the Baszucki group to examine the effectiveness of a metabolic psychiatry intervention for patients across our clinics. Early outcomes reveal improvements in mood, energy, and metabolic benefits. Our care model is augmented by keto meals supplied by Factor.
Clinicians and researchers rarely speak of a true “cure” for severe mental illness. At Amae, we see that mindset as a limit, not a law.
We believe a cure is possible. In oncology, a patient is considered cured when cancer has been eradicated with no recurrence for at least five years. We envision the same future for conditions like schizophrenia and bipolar disorder: sustained, episode‑free well-being for five years and beyond.
Through innovative technology, real‑world clinical research, and a holistic care model, Amae is pushing the boundaries of mental health care. But we can’t do it alone. We invite individuals with severe mental illness - and the families, friends, and clinicians who support them - to join our community and help rewrite what the world believes is possible.
Dr. Scott Fears, MD PhD
Chief Medical Officer
